Titre:
  • An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
Auteur:Viscoli, Claudio; Herbrecht, R; Akan, Hamdi; Baila, L.; Sonet, Alexis; Gallamini, A; Giagounidis, A; Marchetti, Oscar; Martino, Robert; Meert, L; Paesmans, Marianne; Ameye, Lieveke; Shivaprakash, M; Ullmann, Andrew; Maertens, J.; Infectious Disease Group of the EORTC,
Informations sur la publication:Journal of antimicrobial chemotherapy, 64, 6, page (1274-1281)
Statut de publication:Publié, 2009-12
Sujet CREF:Cancérologie
Mots-clés:Acute leukaemia
Echinocandins
Fungal infections
MeSH keywords:Adult
Aged
Aged, 80 and over
Antifungal Agents -- administration & dosage -- therapeutic use
Aspergillosis -- drug therapy
Echinocandins -- administration & dosage -- therapeutic use
Female
Hematologic Neoplasms -- complications
Humans
Male
Middle Aged
Survival Analysis
Transplantation, Autologous -- adverse effects
Treatment Outcome
Young Adult
Note générale:Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0305-7453
info:doi/10.1093/jac/dkp355
info:pii/dkp355
info:scp/76249115229
info:pmid/19841031